Sfoglia per Autore
Herpes zoster in patients with solid tumors treated with immune checkpoint inhibitors
2022-01-01 Serra, F.; Cassaniti, I.; Lilleri, D.; Pedrazzoli, P.; Baldanti, F.; Lasagna, A.
Immunological Aspects of Human Papilloma Virus-Related Cancers Always Says, "I Am like a Box of Complexity, You Never Know What You Are Gonna Get"
2022-01-01 Soleymaninejadian, Ehsan; Zelini, Paola; Cassaniti, Irene; Baldanti, Fausto; Dominoni, Mattia; Gritti, Andrea; Gardella, Barbara
Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients
2022-01-01 Cassaniti, I.; Gregorini, M.; Bergami, F.; Arena, F.; Sammartino, J. C.; Percivalle, E.; Soleymaninejadian, E.; Abelli, M.; Ticozzelli, E.; Nocco, A.; Minero, F.; Pattonieri, E. F.; Lilleri, D.; Rampino, T.; Baldanti, F.
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
2022-01-01 Zuo, F.; Abolhassani, H.; Du, L.; Piralla, A.; Bertoglio, F.; de Campos-Mata, L.; Wan, H.; Schubert, M.; Cassaniti, I.; Wang, Y.; Sammartino, J. C.; Sun, R.; Vlachiotis, S.; Bergami, F.; Kumagai-Braesch, M.; Andrell, J.; Zhang, Z.; Xue, Y.; Wenzel, E. V.; Calzolai, L.; Varani, L.; Rezaei, N.; Chavoshzadeh, Z.; Baldanti, F.; Hust, M.; Hammarstrom, L.; Marcotte, H.; Pan-Hammarstrom, Q.
Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers
2022-01-01 Bergami, F.; Arena, F.; Sammartino, J. C.; Ferrari, A.; Zavaglio, F.; Zelini, P.; Paolucci, S.; Comolli, G.; Percivalle, E.; Lilleri, D.; Cassaniti, I.; Baldanti, F.
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern
2022-01-01 Lasagna, A.; Bergami, F.; Lilleri, D.; Percivalle, E.; Quaccini, M.; Serra, F.; Comolli, G.; Sarasini, A.; Sammartino, J. C.; Ferrari, A.; Arena, F.; Secondino, S.; Cicognini, D.; Schiavo, R.; Lo Cascio, G.; Cavanna, L.; Baldanti, F.; Pedrazzoli, P.; Cassaniti, I.
Characterization of CCP: Can We Use Past Convalescent Plasma from COVID-19 Patients for Treatment of New Emerging Variants?
2022-01-01 Ferrari, Alessandro; Cassaniti, Irene; Sarasini, Antonella; Lilleri, Daniele; Sammartino, JOSE' CAMILLA; DEL FANTE, Claudia; Baldanti, Fausto; Percivalle, Elena; Perotti, Cesare
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study
2022-01-01 Lasagna, A.; Bergami, F.; Lilleri, D.; Percivalle, E.; Quaccini, M.; Alessio, N.; Comolli, G.; Sarasini, A.; Sammartino, J. C.; Ferrari, A.; Arena, F.; Secondino, S.; Cicognini, D.; Schiavo, R.; Lo Cascio, G.; Cavanna, L.; Baldanti, F.; Pedrazzoli, P.; Cassaniti, I.
Adenovirus-vectored SARS-CoV-2 vaccine expressing S1-N fusion protein
2022-01-01 Khan, Muhammad S; Kim, Eun; Mcpherson, Alex; Weisel, Florian J; Huang, Shaohua; Kenniston, Thomas W; Percivalle, Elena; Cassaniti, Irene; Baldanti, Fausto; Meisel, Marlies; Gambotto, Andrea
Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM)
2022-01-01 Pedrazzoli, P; Lasagna, A; Cassaniti, I; Ferrari, A; Bergami, F; Silvestris, N; Sapuppo, E; Di Maio, M; Cinieri, S; Baldanti, F
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up
2022-01-01 Lasagna, A.; Lilleri, D.; Agustoni, F.; Percivalle, E.; Borgetto, S.; Alessio, N.; Comolli, G.; Sarasini, A.; Bergami, F.; Sammartino, J. C.; Ferrari, A.; Zavaglio, F.; Arena, F.; Secondino, S.; Falzoni, M.; Schiavo, R.; Lo Cascio, G.; Cavanna, L.; Baldanti, F.; Pedrazzoli, P.; Cassaniti, I.
SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment
2022-01-01 Ferrari, A.; Cassaniti, I.; Sammartino, J. C.; Mortellaro, C.; Del Fante, C.; De Vitis, S.; Barone, E.; Troletti, D.; Prati, F.; Baldanti, F.; Percivalle, E.; Cesare, P.
Deep learning and machine learning-based voice analysis for the detection of COVID-19: A proposal and comparison of architectures
2022-01-01 Costantini, Giovanni; Cesarini Dr, Valerio; Robotti, Carlo; Benazzo, Marco; Pietrantonio, Filomena; Di Girolamo, Stefano; Pisani, Antonio; Canzi, Pietro; Mauramati, Simone; Bertino, Giulia; Cassaniti, Irene; Baldanti, Fausto; Saggio, Giovanni
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up
2022-01-01 Lasagna, A; Lilleri, D; Agustoni, F; Percivalle, E; Borgetto, S; Alessio, N; Comolli, G; Sarasini, A; Bergami, F; Sammartino, J C; Ferrari, A; Zavaglio, F; Arena, F; Secondino, S; Falzoni, M; Schiavo, R; Lo Cascio, G; Cavanna, L; Baldanti, F; Pedrazzoli, P; Cassaniti, I
Clinical, virological and immunological evolution of the olfactory and gustatory dysfunction in COVID-19
2022-01-01 Maiorano, Eugenia; Calastri, Anna; Robotti, Carlo; Cassaniti, Irene; Baldanti, Fausto; Zuccaro, Valentina; Stellin, Edoardo; Ferretti, Virginia V; Klersy, Catherine; Benazzo, Marco
Infectious complications and immunotherapy: old pitfalls and new horizons
2022-01-01 Lasagna, Angioletta; Cassaniti, Irene; Sacchi, Paolo; Baldanti, Fausto; Bruno, Raffaele; Pedrazzoli, Paolo
Serum and breastmilk SARS-CoV-2 specific antibodies following BNT162b2 vaccine: prolonged protection from SARS-CoV-2 in newborns and older children
2022-01-01 Ricciardi, Alessandra; Zelini, Paola; Cassaniti, Irene; Avanzini, Maria Antonietta; Colaneri, Marta; De Silvestri, Annalisa; Baldanti, Fausto; Bruno, Raffaele
Immunity to SARS-CoV-2 up to 15 months after infection
2022-01-01 Marcotte, H.; Piralla, A.; Zuo, F.; Du, L.; Cassaniti, I.; Wan, H.; Kumagai-Braesh, M.; Andr('e)ll, J.; Percivalle, E.; Sammartino, J. C.; Wang, Y.; Vlachiotis, S.; Attevall, J.; Bergami, F.; Ferrari, A.; Colaneri, M.; Vecchia, M.; Sambo, M.; Zuccaro, V.; Asperges, E.; Bruno, R.; Oggionni, T.; Meloni, F.; Abolhassani, H.; Bertoglio, F.; Schubert, M.; Calzolai, L.; Varani, L.; Hust, M.; Xue, Y.; Hammarstr(\,
Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM)
2023-01-01 Pedrazzoli, P; Lasagna, A; Cassaniti, I; Piralla, A; Squeri, A; Bruno, R; Sacchi, P; Baldanti, F; Di Maio, M; Beretta, G D; Cinieri, S; Silvestris, N
Characterization of immune response against monkeypox virus in cohorts of infected patients, historic and newly vaccinated subjects
2023-01-01 Sammartino, J. C.; Cassaniti, I.; Ferrari, A.; Piralla, A.; Bergami, F.; Arena, F. A.; Paolucci, S.; Rovida, F.; Lilleri, D.; Percivalle, E.; Baldanti, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Herpes zoster in patients with solid tumors treated with immune checkpoint inhibitors | 1-gen-2022 | Serra, F.; Cassaniti, I.; Lilleri, D.; Pedrazzoli, P.; Baldanti, F.; Lasagna, A. | |
| Immunological Aspects of Human Papilloma Virus-Related Cancers Always Says, "I Am like a Box of Complexity, You Never Know What You Are Gonna Get" | 1-gen-2022 | Soleymaninejadian, Ehsan; Zelini, Paola; Cassaniti, Irene; Baldanti, Fausto; Dominoni, Mattia; Gritti, Andrea; Gardella, Barbara | |
| Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients | 1-gen-2022 | Cassaniti, I.; Gregorini, M.; Bergami, F.; Arena, F.; Sammartino, J. C.; Percivalle, E.; Soleymaninejadian, E.; Abelli, M.; Ticozzelli, E.; Nocco, A.; Minero, F.; Pattonieri, E. F.; Lilleri, D.; Rampino, T.; Baldanti, F. | |
| Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant | 1-gen-2022 | Zuo, F.; Abolhassani, H.; Du, L.; Piralla, A.; Bertoglio, F.; de Campos-Mata, L.; Wan, H.; Schubert, M.; Cassaniti, I.; Wang, Y.; Sammartino, J. C.; Sun, R.; Vlachiotis, S.; Bergami, F.; Kumagai-Braesch, M.; Andrell, J.; Zhang, Z.; Xue, Y.; Wenzel, E. V.; Calzolai, L.; Varani, L.; Rezaei, N.; Chavoshzadeh, Z.; Baldanti, F.; Hust, M.; Hammarstrom, L.; Marcotte, H.; Pan-Hammarstrom, Q. | |
| Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers | 1-gen-2022 | Bergami, F.; Arena, F.; Sammartino, J. C.; Ferrari, A.; Zavaglio, F.; Zelini, P.; Paolucci, S.; Comolli, G.; Percivalle, E.; Lilleri, D.; Cassaniti, I.; Baldanti, F. | |
| Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern | 1-gen-2022 | Lasagna, A.; Bergami, F.; Lilleri, D.; Percivalle, E.; Quaccini, M.; Serra, F.; Comolli, G.; Sarasini, A.; Sammartino, J. C.; Ferrari, A.; Arena, F.; Secondino, S.; Cicognini, D.; Schiavo, R.; Lo Cascio, G.; Cavanna, L.; Baldanti, F.; Pedrazzoli, P.; Cassaniti, I. | |
| Characterization of CCP: Can We Use Past Convalescent Plasma from COVID-19 Patients for Treatment of New Emerging Variants? | 1-gen-2022 | Ferrari, Alessandro; Cassaniti, Irene; Sarasini, Antonella; Lilleri, Daniele; Sammartino, JOSE' CAMILLA; DEL FANTE, Claudia; Baldanti, Fausto; Percivalle, Elena; Perotti, Cesare | |
| Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study | 1-gen-2022 | Lasagna, A.; Bergami, F.; Lilleri, D.; Percivalle, E.; Quaccini, M.; Alessio, N.; Comolli, G.; Sarasini, A.; Sammartino, J. C.; Ferrari, A.; Arena, F.; Secondino, S.; Cicognini, D.; Schiavo, R.; Lo Cascio, G.; Cavanna, L.; Baldanti, F.; Pedrazzoli, P.; Cassaniti, I. | |
| Adenovirus-vectored SARS-CoV-2 vaccine expressing S1-N fusion protein | 1-gen-2022 | Khan, Muhammad S; Kim, Eun; Mcpherson, Alex; Weisel, Florian J; Huang, Shaohua; Kenniston, Thomas W; Percivalle, Elena; Cassaniti, Irene; Baldanti, Fausto; Meisel, Marlies; Gambotto, Andrea | |
| Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM) | 1-gen-2022 | Pedrazzoli, P; Lasagna, A; Cassaniti, I; Ferrari, A; Bergami, F; Silvestris, N; Sapuppo, E; Di Maio, M; Cinieri, S; Baldanti, F | |
| Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up | 1-gen-2022 | Lasagna, A.; Lilleri, D.; Agustoni, F.; Percivalle, E.; Borgetto, S.; Alessio, N.; Comolli, G.; Sarasini, A.; Bergami, F.; Sammartino, J. C.; Ferrari, A.; Zavaglio, F.; Arena, F.; Secondino, S.; Falzoni, M.; Schiavo, R.; Lo Cascio, G.; Cavanna, L.; Baldanti, F.; Pedrazzoli, P.; Cassaniti, I. | |
| SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment | 1-gen-2022 | Ferrari, A.; Cassaniti, I.; Sammartino, J. C.; Mortellaro, C.; Del Fante, C.; De Vitis, S.; Barone, E.; Troletti, D.; Prati, F.; Baldanti, F.; Percivalle, E.; Cesare, P. | |
| Deep learning and machine learning-based voice analysis for the detection of COVID-19: A proposal and comparison of architectures | 1-gen-2022 | Costantini, Giovanni; Cesarini Dr, Valerio; Robotti, Carlo; Benazzo, Marco; Pietrantonio, Filomena; Di Girolamo, Stefano; Pisani, Antonio; Canzi, Pietro; Mauramati, Simone; Bertino, Giulia; Cassaniti, Irene; Baldanti, Fausto; Saggio, Giovanni | |
| Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up | 1-gen-2022 | Lasagna, A; Lilleri, D; Agustoni, F; Percivalle, E; Borgetto, S; Alessio, N; Comolli, G; Sarasini, A; Bergami, F; Sammartino, J C; Ferrari, A; Zavaglio, F; Arena, F; Secondino, S; Falzoni, M; Schiavo, R; Lo Cascio, G; Cavanna, L; Baldanti, F; Pedrazzoli, P; Cassaniti, I | |
| Clinical, virological and immunological evolution of the olfactory and gustatory dysfunction in COVID-19 | 1-gen-2022 | Maiorano, Eugenia; Calastri, Anna; Robotti, Carlo; Cassaniti, Irene; Baldanti, Fausto; Zuccaro, Valentina; Stellin, Edoardo; Ferretti, Virginia V; Klersy, Catherine; Benazzo, Marco | |
| Infectious complications and immunotherapy: old pitfalls and new horizons | 1-gen-2022 | Lasagna, Angioletta; Cassaniti, Irene; Sacchi, Paolo; Baldanti, Fausto; Bruno, Raffaele; Pedrazzoli, Paolo | |
| Serum and breastmilk SARS-CoV-2 specific antibodies following BNT162b2 vaccine: prolonged protection from SARS-CoV-2 in newborns and older children | 1-gen-2022 | Ricciardi, Alessandra; Zelini, Paola; Cassaniti, Irene; Avanzini, Maria Antonietta; Colaneri, Marta; De Silvestri, Annalisa; Baldanti, Fausto; Bruno, Raffaele | |
| Immunity to SARS-CoV-2 up to 15 months after infection | 1-gen-2022 | Marcotte, H.; Piralla, A.; Zuo, F.; Du, L.; Cassaniti, I.; Wan, H.; Kumagai-Braesh, M.; Andr('e)ll, J.; Percivalle, E.; Sammartino, J. C.; Wang, Y.; Vlachiotis, S.; Attevall, J.; Bergami, F.; Ferrari, A.; Colaneri, M.; Vecchia, M.; Sambo, M.; Zuccaro, V.; Asperges, E.; Bruno, R.; Oggionni, T.; Meloni, F.; Abolhassani, H.; Bertoglio, F.; Schubert, M.; Calzolai, L.; Varani, L.; Hust, M.; Xue, Y.; Hammarstr(\, | |
| Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) | 1-gen-2023 | Pedrazzoli, P; Lasagna, A; Cassaniti, I; Piralla, A; Squeri, A; Bruno, R; Sacchi, P; Baldanti, F; Di Maio, M; Beretta, G D; Cinieri, S; Silvestris, N | |
| Characterization of immune response against monkeypox virus in cohorts of infected patients, historic and newly vaccinated subjects | 1-gen-2023 | Sammartino, J. C.; Cassaniti, I.; Ferrari, A.; Piralla, A.; Bergami, F.; Arena, F. A.; Paolucci, S.; Rovida, F.; Lilleri, D.; Percivalle, E.; Baldanti, F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile